Business Context and Reporting Period
Huron Consulting Group Inc. filed its Form 10-K for the fiscal year ended December 31, 2021. Huron is a professional services and technology consultancy serving healthcare, business advisory, and education clients. Revenue mix was 42% Healthcare, 32% Business Advisory, and 26% Education. The company served more than 1,900 clients; its 10 largest clients represented approximately 19% of consolidated revenue.
Effective January 1, 2022, Huron reorganized its reporting structure into Healthcare, Education, and Commercial industries and began reporting revenue across Consulting and Managed Services and Digital capabilities. Historical segment information was expected to be recast during 2022.
Financial Results and Key Metrics
| Metric | 2021 | 2020 | Change |
|---|---|---|---|
| Revenue | $905.6 million | $844.1 million | Up 7.3% |
| Total revenue and reimbursable expenses | $927.0 million | $871.0 million | Up 6.4% |
| Operating income (loss) | $52.8 million | $(28.9) million | Improved $81.7 million |
| Operating margin | 5.8% | (3.4)% | Improved |
| Net income (loss) | $63.0 million | $(23.8) million | Improved $86.8 million |
| Diluted EPS | $2.89 | $(1.09) | Turned profitable |
| Adjusted EBITDA | $97.8 million | $87.1 million | Up 12.3% |
| Adjusted EBITDA margin | 10.8% | 10.3% | Up 50 basis points |
| Adjusted net income | $56.9 million | $47.9 million | Up 18.8% |
| Adjusted diluted EPS | $2.61 | $2.15 | Up 21.4% |
Revenue growth reflected stronger demand across all segments, higher average billing rates, improved overall consultant utilization, acquisitions, and growth in Healthcare Managed Services. Fixed-fee arrangements represented 44.2% of revenue, time-and-expense arrangements 39.2%, performance-based arrangements 10.1%, and software support, maintenance, and subscriptions 6.5%.
- Healthcare revenue rose 6.8% to $377.6 million; segment operating margin increased to 27.5% from 26.9%.
- Business Advisory revenue rose 9.1% to $291.7 million; segment margin declined to 16.5% from 18.0%.
- Education revenue rose 5.9% to $236.4 million; segment margin increased to 22.3% from 21.3%.
- Overall billable consultant utilization increased to 71.1% from 70.7%, while the average billing rate increased to $209 per hour from $202.
- Healthcare Managed Services revenue increased to $47.7 million from $28.7 million, supported by a group hire of approximately 300 employees in 2021.
Cash Flow, Liquidity, Debt, and Capital Allocation
- Operating cash flow was $18.0 million, down from $136.7 million in 2020. The decrease primarily reflected lower collections, higher employee-related payments, and repayment of $12.2 million of deferred employer Social Security taxes.
- Investing cash flow was $(20.1) million, including $44.8 million for acquisitions, $10.9 million for property and equipment, and $4.9 million for internally developed software, partly offset by $41.3 million of proceeds from the Life Sciences divestiture.
- Cash and cash equivalents declined to $20.8 million from $67.2 million.
- Debt totaled $232.8 million at year-end, comprising $230.0 million under the senior secured revolving facility and $2.8 million under a promissory note.
- The $600 million revolving facility had $369.3 million of unused borrowing capacity, after considering borrowings and letters of credit. The facility matures September 27, 2024.
- Huron was in compliance with its debt covenants. Consolidated leverage was 1.73x versus a 3.75x maximum, and interest coverage was 18.43x versus a 3.50x minimum.
- Huron repurchased $64.8 million of common stock in 2021 and had $30.2 million remaining under its $100 million repurchase authorization at year-end. The company has not paid common stock dividends since becoming public.
- Management stated that cash on hand, internally generated liquidity, and available revolver capacity should support current needs and the long-term growth strategy.
Material Changes and Unusual Items
- 2021 results benefited from the absence of the $59.8 million non-cash goodwill impairment charge recorded in 2020.
- Huron recorded a $31.5 million pretax gain on the November 2021 sale of its Life Sciences business. The business generated $16.7 million of revenue during the first ten months of 2021 and was not classified as discontinued operations.
- Restructuring charges declined to $12.4 million from $20.5 million. The 2021 charges included $8.5 million associated with the Life Sciences divestiture and costs related to office reductions and the operating-model reorganization.
- Huron completed acquisitions of Unico Solutions, Bad Rabbit, Whiteboard Communications, and Perception Health. The acquisitions were not material individually or in aggregate for 2021.
- On January 18, 2022, Huron acquired AIMDATA, an advisory and implementation consulting firm. The filing states the acquisition was not significant to the consolidated financial statements.
- Goodwill totaled $620.9 million, or approximately 55% of total assets, and goodwill plus other intangible assets totaled $652.8 million, or 58% of total assets. No goodwill impairment was identified in the 2021 annual assessment.
- Huron’s $65.9 million Shorelight convertible debt investment was carried at fair value and remained in an unrealized gain position; no credit allowance was recorded.
Guidance, Outlook, Commentary, and Risks
Management expected continued revenue growth in 2022 compared with 2021 and described the primary financing need as funding long-term growth through new hires, acquisitions, geographic expansion, and related capital expenditures. Estimated 2022 spending for property, equipment, and software development was approximately $20 million to $25 million.
Management cited stronger demand beginning in the second quarter of 2021, particularly for digital, technology, analytics, restructuring, and capital advisory services. COVID-19 continued to affect client decision-making, project timing, work methods, and demand in certain Healthcare and Education offerings, although employees primarily continued working remotely at year-end.
- Revenue recognition depends on estimates for fixed-fee completion percentages and performance-based fees. Performance-based revenue was 10.1% of 2021 revenue, including $73.4 million in Healthcare.
- Client contracts are often engagement-based, short-term, and terminable with little or no notice, creating utilization and revenue volatility.
- The business is labor-intensive and exposed to competition for consultants, wage inflation, retention risk, utilization changes, and billing-rate pressure.
- Healthcare and Education clients face substantial regulatory, reimbursement, demographic, enrollment, and funding uncertainty.
- Debt is secured by substantially all of Huron’s and certain subsidiaries’ assets and carries variable-rate exposure. The company also faced the transition away from LIBOR.
- Goodwill and intangible assets are subject to impairment risk if operating performance, projected cash flows, market multiples, or broader economic conditions deteriorate.
- Huron disclosed an ongoing Oaktree bankruptcy-related lawsuit alleging fiduciary duty, negligence, fraud, breach of contract, and other claims. The trustee seeks unspecified damages; Huron believes the claims are without merit, but stated that potential liability could not be estimated.
- Additional risks include cybersecurity and data privacy, professional liability, acquisition integration, international operations including India, foreign exchange, tax changes, third-party technology relationships, and economic or geopolitical disruption.
Management and the independent auditor concluded that disclosure controls and internal control over financial reporting were effective as of December 31, 2021.
Investor Verification Items
- Verify the sustainability of revenue growth and adjusted EBITDA improvement after excluding the $31.5 million Life Sciences divestiture gain and other adjustments.
- Assess the sharp decline in operating cash flow and the conversion of earnings to cash, including changes in receivables and unbilled services.
- Monitor leverage, revolver utilization, covenant compliance, maturity obligations in 2024, and the effect of LIBOR replacement on borrowing costs.
- Review the impact of the 2022 segment reorganization and the recast historical results on segment growth and margins.
- Evaluate performance-based and fixed-fee revenue estimates, including potential reversals or margin pressure on complex engagements.
- Track goodwill concentration, the Shorelight investment, acquisition valuations, and any future impairment indicators.
- Follow developments in the Oaktree litigation and any related financial exposure.
- Confirm 2022 guidance, capital expenditure plans, acquisition activity, and the pace of post-pandemic demand recovery.